Last week Mae, a maternal health tech startup focused on providing critical resources to Black expectant mothers in the U.S. announced their soft-launch. ´The platform features a free birth planning tool that anyone can access, and free 15 minute consults with doulas for interested expectant mothers. The platform’s founder Maya Hardigan explains: “Mae is a digital health platform that elevates the standard of care for Black…
To study perinatal depression in women – before and after childbirth – and possible new treatments, The Feinstein Institutes for Medical Research has been awarded more than $4 million in multi-year grants. The research will be led by Kristina Deligiannidis, MD, associate professor at the Feinstein Institutes’ Institute of Behavioral Science. The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care…
Pregna has recently announced the launch of its cryotherapy device CryoPop. The product was developed by Jhpiego with an objective of making treatment of cervical pre-cancerous lesions accessible to all. Pregna is the exclusive global commercialising partner for the device. “Cervical cancer is one of the most common and fatal forms of cancer in women worldwide, with about 85% of these deaths occurring in low and…
You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.
Runway Growth Capital, a provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, announced today the closing of a senior secured term loan of $50 million to Gynesonics, a healthcare company focused on advancing women’s health by developing minimally invasive, incision-free, uterus-preserving, transcervical technologies for diagnostic and therapeutic applications. Gynesonics has developed and has received FDA clearance for…
Advantia Health today announced that veteran healthcare executive Vincent Bradley has joined the company as Chief Executive Officer. Advantia Health’s Co-Founder, Sean Glass, will continue in his role on the company’s board of directors. “As I decided that the time was right to recruit my successor into Advantia, I was looking to find an experienced healthcare CEO aligned with our mission of transforming…
Lina Behrens is the Managing Director of Flying Health, the leading ecosystem for Next Generation Healthcare and spends her days guiding industry leaders and digital health entrepreneurs as they explore and create tomorrow’s healthcare together. Beyond her daily work at Flying Health, Lina is a passionate advocate for female leadership and female entrepreneurship. She is a Vice President of the German Startup…
BioAesthetics Corporation today announced that it has doubled its initial Series A funding goal of $2.5 million, closed on Dec. 30, 2020, at $5 million to commercialize its NACgraft biologic matrix— a regenerative nipple graft for breast cancer survivors. BioAesthetics’ Series A was co-led by FemHealth Ventures and personally by BioAesthetics’ Director Sandra Coufal, MD, of Sibling Capital Ventures. BioAesthetics’ inaugural product, the NACgraft — for patients…
